Single and Combined Modality Trans-Oral Robotic Surgery in Early Oropharyngeal Cancer
NCT05933889 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2024-08-07
Summary
Multi-centre retrospective observational cohort study with optional exploratory radiomic study (international) and prospective molecular analysis studies (UK only).
Conditions
- Cancer Head Neck
Interventions
- GENETIC
-
Molecular Analysis
Germline and circulating tumour DNA analysis of buccal/ blood samples and molecular analysis of primary and recurrent tumour tissue samples
- OTHER
-
Radiomic/ Morphological analysis
Radiomic analysis and assessment of morphological features of pre-operative CT/ MRI imaging in patients who have undergone TORS for primary oropharyngeal cancer.
Sponsors & Collaborators
-
Royal Marsden NHS Foundation Trust
lead OTHER
Principal Investigators
-
Vinidh Paleri · Royal Marsden Hospital NHS Foundation Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-19
- Primary Completion
- 2027-08-31
- Completion
- 2027-08-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer
NCT01254734 ·Status: TERMINATED ·Phase: NA
-
Value of Geriatric Screening to Predict Postoperative Morbidity for Head and Neck Cancer
NCT03053310 ·Status: ACTIVE_NOT_RECRUITING
-
Exploratory Study of Clonal Evolution in Cancer for Patients Undergoing Transoral Robotic Surgery for Radiation Exposed Residual/reCurrent Tumours of the Upper Aerodigestive Tract
NCT04671940 ·Status: RECRUITING
-
A Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selective Neck Dissection (SND) Followed by Adjuvant Radiation Therapy (+/- Chemotherapy) to the Regional Nodes for Advanced Stage, Human Papilloma Virus (HPV) Positive, Oropharyngeal Cancer
NCT02159703 ·Status: COMPLETED ·Phase: PHASE2
-
Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell
NCT02663583 ·Status: UNKNOWN
-
Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
NCT06380686 ·Status: RECRUITING
-
A Study of Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma
NCT01046266 ·Status: COMPLETED ·Phase: PHASE1
-
Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma
NCT05328024 ·Status: RECRUITING
-
A Prospective Study of Monitoring Immune Response in Locally Advanced Cervix Cancer
NCT03559803 ·Status: UNKNOWN ·Phase: NA
-
A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
NCT06894459 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Radiotherapy vs. Trans-Oral Surgery for HPV-Negative Oropharyngeal Squamous Cell Carcinoma
NCT04220749 ·Status: RECRUITING ·Phase: PHASE2
-
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
NCT01473784 ·Status: RECRUITING ·Phase: NA
-
Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT04428333 ·Status: TERMINATED ·Phase: PHASE3
-
Neck Surgery in Treating Patients With Early-Stage Oral Cancer
NCT00571883 ·Status: UNKNOWN ·Phase: NA
-
Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma
NCT02984410 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Transoral Robotic Surgery and Tailored Radiotherapy in Unknown Primary and Small Squamous Cell Head and Neck Cancer
NCT03281499 ·Status: COMPLETED ·Phase: NA
-
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
NCT05388773 ·Status: RECRUITING ·Phase: PHASE2
-
Role of Microbiome as a Biomarkers in Locoregionally-Advanced Oropharyngeal Squamous Cell Carcinoma 2
NCT03838601 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer
NCT00665392 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Phase II Study of Sentinel Node Detection in Squamous Cell Carcinoma T1-T2N0 of the Oropharynx Treated With Radiotherapy and Larynx Treated by Surgery, Laser or Robot
NCT03010553 ·Status: UNKNOWN ·Phase: PHASE2
-
Confocal Micro-endoscopy in Head and Neck Cancer/Micro Endoscopie Confocale (MEC)Oto-Rhino-Laryngologie (ORL)
NCT01626638 ·Status: COMPLETED ·Phase: NA
-
Anti-tumor Specific Immune Response in Head and Neck Cancers
NCT02881918 ·Status: UNKNOWN
-
Comparing the Efficacy of Surgery Staging and Image Staging of Locally Advanced Cervical Cancer
NCT05378087 ·Status: RECRUITING ·Phase: NA
-
Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCC
NCT02707588 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers
NCT04086849 ·Status: COMPLETED